SAVA
Cassava Sciences Inc
Price:  
2.89 
USD
Volume:  
3,232,755.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAVA WACC - Weighted Average Cost of Capital

The WACC of Cassava Sciences Inc (SAVA) is 7.1%.

The Cost of Equity of Cassava Sciences Inc (SAVA) is 10.60%.
The Cost of Debt of Cassava Sciences Inc (SAVA) is 5.00%.

Range Selected
Cost of equity 8.80% - 12.40% 10.60%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 8.0% 7.1%
WACC

SAVA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.07 1.34
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.80% 12.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 8.0%
Selected WACC 7.1%